Skip to main content
Home
  • About Terumo India
      1. Col 1
        1. About Terumo India
      2. Col 2
        1. Dear Stakeholders
        2. Who We Are
        3. At a Glance
        4. Terumo Group Identity
      3. Col 3
        1. Leadership Team
        2. History
        3. Terumo's Purpose
        4. Response to COVID-19
  • Business Overview
      1. Col 1
        1. Business Overview
      2. Col 2
        1. TIS Division (Terumo Interventional Systems)
        2. Cardiovascular Division (Terumo Cardiovascular)
        3. Vascular Graft Division (Terumo Aortic)
      3. Col 3
        1. Life Care Solutions Division
        2. Pharmaceutical Solutions Division
  • Sustainability
      1. col 1
        1. Sustainability
      2. col 2
        1. CSR Initiatives
        2. CSR Policy & Committee
      3. col 3
        1. Award & Recognition
        2. Creating a Diverse and Inclusive Workplace
  • Technology
      1. col 1
        1. Technology Overview
      2. col 2
        1. Basic Information
      3. col 3
        1. Stories - Our Technologies
  • News
      1. Col 1-4
        1. News
      2. Col 2-2
        1. Col 2-4
          • December 12, 2022
          • Financial
          • Notification of Completion of Acquisition and Cancellation of Own Shares (PDF 115.79 KB) (Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation)
        2. Col 3-4
          • December 8, 2022
          • Corporate
          • Ultimaster Drug Eluting Stent family (Terumo) first stent to receive the mention 1-month DAPT in the reimbursement conditions in France
        3. Col 4-4
          • December 06, 2022
          • Corporate
          • Terumo Announces Launch of Drug-Device Combination Product Co-Developed with Kyowa Kirin
  • Global Network
      1. Col 1
        1. Global Network
      2. Col 2
        1. Japan
        2. North America
        3. South America
      3. Col 3
        1. EMEA
        2. Greater China
        3. Asia and Pacific
  1. Home
  2. Our Culture

Pages Menu 1

  • Our Culture
  • Diversity, Equity & Inclusion
  • Developing our Associates
  • Campus Connect

Our Culture

culture
Click Here To Know More


Contact Us
Move to topTop

Revised MRP of Terumo’s Coronary Stent pdf

About Terumo

  • About Terumo
  • Dear Stakeholders
  • Who We Are
  • At a Glance
  • Terumo Group Identity
  • Leadership Team
  • History
  • Terumo's Purpose
  • Response to COVID-19

Business Overview

  • Business Overview
  • TIS Division (Terumo Interventional Systems)
  • Cardiovascular Division (Terumo Cardiovascular)
  • Vascular Graft Division (Terumo Aortic)
  • Life Care Solutions Division
  • Pharmaceutical Solutions Division

Sustainability

  • Sustainability Overview
  • CSR Initiatives
  • CSR Policy & Committee
  • Award & Recognition
  • Creating a Diverse and Inclusive Workplace

Technology

  • Technology Overview
  • Basic Information
  • Stories - Our Technologies

Global Network

  • Japan
  • North America
  • South America
  • EMEA
  • Greater China
  • Asia and Pacific

Footer Bottom

  • Terms and Conditions of Use
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
  • Site Map

Copyright © 2022 Terumo India Pvt Ltd, All Rights Reserved.